It's time to revisit a company I haven't covered in quite a while. As the title of this article gave away, that company is ResMed (RMD), a fast-growing healthcare company. Since then, shares have ...

ResMed is rated a buy due to strong fundamentals, expanding margins, robust cash flow, and resilience in recessionary environments. RMD's steady topline growth, high profitability, low debt, and ...